Switch to
More onapp

How to use scorecard? Learn more

Natco Pharma Ltd

NATCOPHARM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹18,407 cr, stock is ranked 318
High RiskStock is 3.22x as volatile as Nifty
1,027.7018.80 (+1.86%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹18,407 cr, stock is ranked 318
High RiskStock is 3.22x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
14.41
PB RatioPB Ratio
3.78
Dividend YieldDiv. Yield
0.55%
Sector PESector PE
52.65
Sector PBSector PB
6.03
Sector Div YldSctr Div Yld
0.60%

Forecast & RatingsDetailed Forecast 

64%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Natco Pharma Limited is a research and development (R&D)-focused pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs).

Brands

Natco Pharma

Pharmaceutical company

Investor PresentationView older 

Aug 10, 2023

PDF
View Older Presentations

Brands

Natco Pharma

Pharmaceutical company

Financial TrendFinancial statements 

20202021202220232.022.162.042.810.460.440.170.72
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Decreased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has decreased by 2.46%

See detailed holdings

Recent EventsAll events 

Notice Of Shareholders Meetings-XBRL 
Announced OnFeb 22, 2024

NATCO PHARMA LIMITED has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot | Download

NATCO PHARMA LIMITED has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot | Download

Shareholders meeting 
Announced OnFeb 22, 2024

Natco Pharma Limited has informed the Exchange regarding Notice of Postal Ballot | Download

Natco Pharma Limited has informed the Exchange regarding Notice of Postal Ballot | Download

Cash Dividend 
Ex. DateNov 24, 2023

Interim 2 • Div/Share: ₹ 1.25

See all events